Has Cardiac Pacing a Role in Vasovagal Syncope?

Journal of Interventional Cardiac Electrophysiology

Volumn 9, Issue 2, 2003, Pages 145-149

  Sutton, Richard ^a,b  

^a R Brompton Chelsea Westminster Hos   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONFERENCE PAPER; DUAL CHAMBER HEART PACING; EVIDENCE BASED MEDICINE; HEART PACING; HEART RATE; HUMAN; HYSTERESIS; METHODOLOGY; PACING RATE HYSTERESIS; PRIORITY JOURNAL; SYNCOPE;

CARDIAC OUTPUT; CARDIAC PACING, ARTIFICIAL; HEART ARREST; HUMANS; RANDOMIZED CONTROLLED TRIALS; SYNCOPE, VASOVAGAL;

EID: 0242680370     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026272004709     Document Type: Conference Paper

References (27)

1. Fitzpatrick AP, Travill CM, Vardas PE, et al. Recurrent symptoms after ventricular pacing in unexplained syncope. Pacing Clin Electrophysiol 1990;13:619-624.
2. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: A useful test for the investigation of unexplained syncope. Lancet 1986;2:1352-1355.
3. Fitzpatrick AP, Theodorakis G, Ahmed R, et al. Dual chamber pacing aborts vasovagal syncope induced by head-up 60° tilt. Pacing Clin Electrophysiol 1991;14:13-19.
4. Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in prevention of upright tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1993;3:36-41.
5. Sra JS, Jazayeri MR, Avitail B, et al. Comparison of cardiac pacing with drug therapy and the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. New Engl J Med 1993;328:1085-1090.
6. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-281.
7. Sutton R, Petersen MEV, Brignole M, et al. Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992;2:108-183.
8. Sutton R for the vasovagal international study (VASIS). Is dual chamber pacing efficacious in treatment of neurally mediated tilt positive cardioinhibitory syncope? Pacemaker vs. no therapy: A multi-centre randomized study. Eur J Cardiac Pacing Electrophysiol 1993;3:169-172.
9. Sheldon RS, Gent M, Roberts RS, et al. North American vasovagal pacemaker study: Study design and organization. Pacing Clin Electrophysiol 1997;20:827-828.
10. Sutton R, Petersen MEV. First steps towards a pacing algorithm for vasovagal syncope. Pacing Clin Electrophysiol 1997;20:829-831.
11. Benditt D, Sutton R, Gammage MD, et al. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pacing Clin Electrophysiol 1997;20:183-189.
12. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33: 16-20.
13. Sutton R. Pacing for amelioration of vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1997;7:44-45.
14. Sheldon R, Rose S. Components of clinical trials for vasovagal syncope. Europace 2001;3:233-240.
15. Sutton R, Brignole M, Menozzi C, et al. Dual chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multi-centre randomized study. Circulation 2000;102:294-299.
16. Ammirati F, Colivicchi F, Toscano S, et al. DDD pacing with rate-drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope. Pacing Clin Electrophysiol 1998;21:2178-2181.
17. Kurbaan AS, Franzen AC, Stack Z, Heaven D, Mathur G, Sutton R. Determining the optimal pacing intervention rate for vasovagal syncope. J Intervent Card Electrophysiol 2000;4:483-589.
18. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multi-centre, randomized, controlled trial. Circulation 2001;104:52-57.
19. Fitzpatrick AP, Ahmed R, Williams S, Sutton R. A randomized trial of medical therapy in 'malignant vasovagal syndrome' or 'neurally mediated bradycardia hypotension syndrome.' Eur J Cardiac Pacing Electrophysiol 1991;1: 99-102.
20. Mahanonda N, Bhuripanjo K, Kangkagate C, et al. Randomized, double-blind, placebo-controlled trial of oral Atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250-1253.
21. Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of Atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: A prospectus, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554-559.
22. Connolly SJ, Sheldon R, Thorpe KE, et al. for VPS 2 investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. Second vasovagal pacemaker study (VPS-2): A randomized trial. JAMA 2003;209:2224-2229.
23. Raviele A, Giada F, Sutton R, et al. The vasovagal syncope and pacing (SYNPACE) trial: Rationale and study design. Europace 2001;3:336-341.
24. Giada F, Raviele A, Menozzi C, Speca G, Grazi S, Gasparini G, Sutton R. The vasovagal syncope and pacing trial (SYNPACE): A randomized placebo controlled study of permanent cardiac pacing for treatment of recurrent vasovagal syncope (Abstract). Pacing Clin Electrophysiol 2003;26:1016.
25. Ammirati F, Colivicchi F, Altamura V, et al. Permanent cardiac pacing for recurrent vasovagal syncope refractory to pharmacological treatment: Long-term effect of different pacing modalities (Abstract). Pacing Clin Electrophysiol 2002;24:599.
26. Kurbaan AS, Freanzen A-C, Heaven D, et al. Cardioinhibition during tilt testing identifies patients who may benefit from pacing. Pacing Clin Electrophysiol 2000;23:1792-1794.
27. Kurbaan AS, Erickson M, Petersen ME, et al. Respiratory changes in vasovagal syncope. J Cardiovasc Electrophysiol 2000;11:607-611.